This episode currently has no reviews.
Submit ReviewCharles Fisher’s AI startup has attracted some significant capital as it works to speed up solutions for both pharma companies, and their patients. His venture, Unlearn, has attracted funding from top-tier investors like Mubadala Capital Ventures, Insight Partners, Radical Ventures, and DCVC Bio.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review